Halting Avandia Use Hikes Blood Sugar Levels
Study found diabetics who discontinued drug had less treatment, worse management of disease
THURSDAY, April 16 (HealthDay News) -- Many patients who stopped using the diabetes drug rosiglitazone (Avandia) due to concerns about the drug's safety received less treatment and developed hig...
LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
LegalView continued to maintain its newsworthy coverage on its Avandia
information portal with the recent addition of several new articles detailing the drug's potentially dangerous side effects. The type 2 diabetes drug has been linked to bone fracture, osteoporosis and heart failure among pati...
Public Citizen Petitions FDA to Ban Diabetes Drug Avandia, According to Avandia Plaintiffs Attorney Group
National non-profit organization documents upsurge in negative clinical data associated with use of Avandia, urges FDA commissioner to remove drug from U.S. market immediately
Mineola, N.Y. (Lexis Nexis) November 6, 2008 -- Public Citizen, a non-profit organization repr...
LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
LegalView reintroduced its Avandia
practice area to include updated information for victims of the drug's side effects. Avandia
has been linked to the development of early on-set osteoporosis and heart failure among patients.
Denver (PRWEB) October 21, 2008 -- LegalView...
Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis
Nearly Three-Quarters of Physicians Have Switched Patients to Merck's Januvia, According to a New Report from Decision Resources
WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and
healthcare issues, ...
Older Diabetics Using Avandia Face Increased Death Risk
Canadian study also found those over 65 more likely to have heart trouble with drug
TUESDAY, Dec. 11 (HealthDay News) -- Older patients using the diabetes drug Avandia
faced an increased risk of heart attack, heart failure and even death, new research shows.
According to the Canadi...
Diabetes Drug Avandia Could Weaken Bones
Mouse study suggests it boosts production of bone-eroding cells
MONDAY, Dec. 3 (HealthDay News) -- Avandia, a drug used by millions of diabetes patients, may contribute to bone loss, according to a new study conducted in mice.
Experts fear that, over the long term, Avandia
Diabetes Drug Avandia Boosts Heart Risks: Study
Another study finds a similar drug, Actos, may be a better choice, researchers say
TUESDAY, Sept. 11 (HealthDay News) -- A controversial drug called Avandia, used by millions of diabetics to control blood sugar, greatly increases their risk of heart attack and heart failure, researcher...
Consumer Group Seeks FDA Ban on Avandia
Public Citizen cites liver failure deaths, other risks of adverse events for diabetes drug
THURSDAY, Oct. 30 (HealthDay News) -- The diabetes drug Avandia
should be banned in the United States because it can cause death from liver failure and poses many other life-threatening risks th...
Controversy Spikes Over Anti-diabetes Drug Avandia
Controversy over diabetes drug Avandia
heated up Wednesday as experts pointed to studies linking it to greater heart attack risk, while a GSK study claimed rosiglitazone is safe.
The GlaxoSmithKline study published online Tuesday by the New England Journal of Medicine (NEJM) gave preliminary ...
Avandia in Medical Technology
Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines
RECORD trial also demonstrates durable blood sugar control over time with Avandia
LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 5 /PRNewswire/ -- Clinical trial results presented today at the American Diabetes Association annual meeting show that overall rates of cardiovascular ...
MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA
NEW YORK, June 9 /PRNewswire/ --
Monday, June 9th, 2008 1:00 PM - 1:15 PM ET Galaxy 26 Transponder 24 C-Band Downlink Freq: 4180 H
NEWS: LARGE, LONG-TERM VETERANS AFFAIRS DIABETES TRIAL (VADT) REVEALS IMPORTANT CARDIOVASCULAR SAFETY NEWS ON AVANDIA
Interim Data From RECORD Study Show No Significant Difference
Between Avandia and Standard Therapy in Risk of Cardiovascular
Hospitalization or Death
"Patients and physicians should find these data reassuring"
PHILADELPHIA, June 05, 2007 /PRNewswire-FirstCall/ --
GlaxoSmithKline said today that findings from an interim analysis
of RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and
Regulation of glycemia in Diabetes), a prospective clinica...
Newly Published Data from Large Study Support Cardiovascular Safety
of Avandia (Rosiglitazone Maleate)
Results show risk of heart attack
comparable to two widely used diabetes medicines
LONDON , June 6, 2007 - A study
of more than 33,000 type 2 diabetes patients in a real-world
setting was published today. This study shows that the incidence of
hospitaliations for heart attack, an...
Reaction to Avandia Warnings Stronger Among Internists Than
Endocrinologists, According to Study by GfK Market Measures
EAST HANOVER, N.J.--(BUSINESS WIRE)--Jul 11, 2007 - Since the May
2007 release of a New England Journal of Medicine (NEJM) report
users are 43 percent more likely to suffer a heart
attack and 67 percent more likely to die of cardiovascular causes
than non-users of Avandia, it is no sur...
FDA Issues Safety Alert on Avandia
ROCKVILLE, Md., May 21, 2007-The U.S. Food and Drug Administration
(FDA) is aware of a potential safety issue related to Avandia
(rosiglitazone), a drug approved to treat type 2 diabetes. Safety
data from controlled clinical trials have shown that there is a
potentially significant increase in the ...
Spherix Elects New Independent Director, and Elects Chairman of the Board
...ales and marketing functions, and was actively involved in the promotion of avandia
and the subsequent combinations of avandia
with metformin and a sulfonylurea from the time of their respective market ...
GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
...profile for AVANDIA.
Patients being treated with avandia
or other medicines to control blood
sugar levels s...eir doctor advises a
different course of action.
has been shown to be a safe and highly effective t.... GSK strongly supports the
safety and efficacy of avandia
based on extensive clinical trial experience
FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
... Data Provides Further Information on avandia
as a Safe and Effective Treatment Option for...ial
(ADOPT), a 4- to- 6 year head-to-head study of avandia
versus metformin and
glyburide monotherapy in rece...ly 15 percent with
AVANDIA. The difference between avandia
and the comparators was
Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R)
VADT, there is no evidence to suggest that use of avandia
risk for CV mortality and morbidity ...rdiovascular Risk in Diabetes
(ACCORD), found that avandia
was not associated with any increased risk of
deat...ion (ADA) in
San Francisco, CA.
"The findings on avandia
should be reassuring to physicians who
Avandia in Biological Technology